Chemoinformaics analysis of 1,7,7-TRIMETHYLBICYCLO[2.2.1]HEPTAN-2-OL
| Molecular Weight | 154.253 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 8 |
| Exact Molecular Weight | 154.136 | nRing | 2 |
| Solubility: LogS | -2.67 | nHRing | 0 |
| Solubility: LogP | 2.719 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 1 | BPOL | 18.0577 |
| QED | 0.567 |
| Synth | 4.28 |
| Natural Product Likeliness | 2.542 |
| NR-PPAR-gamma | 0.065 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.002 |
| HIA | 0.005 |
| CACO-2 | -4.442 |
| MDCK | 0.0000247 |
| BBB | 0.915 |
| PPB | 0.776728 |
| VDSS | 1.074 |
| FU | 0.373736 |
| CYP1A2-inh | 0.083 |
| CYP1A2-sub | 0.496 |
| CYP2c19-inh | 0.052 |
| CYP2c19-sub | 0.902 |
| CYP2c9-inh | 0.113 |
| CYP2c9-sub | 0.841 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.776 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.213 |
| CL | 13.693 |
| T12 | 0.276 |
| hERG | 0.021 |
| Ames | 0.011 |
| ROA | 0.103 |
| SkinSen | 0.59 |
| Carcinogencity | 0.071 |
| EI | 0.978 |
| Respiratory | 0.89 |
| NR-Aromatase | 0.011 |
| Antiviral | No |
| Prediction | 0.933817 |